The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of cisplatin-induced hearing loss (CIHL) on patient-reported social and emotional functioning.
 
Victoria Sanchez
Consulting or Advisory Role - Autifony Therapeutics; Otonomy; Pipeline Medical
Research Funding - Frequency Therapeutics (Inst); Otonomy (Inst)
 
Megan Shuey
No Relationships to Disclose
 
Paul C. Dinh
No Relationships to Disclose
 
Patrick Monahan
Stock and Other Ownership Interests - RestUp
 
Howard D. Sesso
Research Funding - Mars Symbioscience (Inst); Pfizer (Inst)
 
Mary Eileen Dolan
No Relationships to Disclose
 
Sophie D. Fossa
No Relationships to Disclose
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen
 
David J. Vaughn
Research Funding - Astellas Pharma (Inst); Merck Sharp & Dohme (Inst)
 
Neil E. Martin
No Relationships to Disclose
 
Chunkit Fung
Consulting or Advisory Role - Exelixis; Novartis; Novartis
Research Funding - Astellas Pharma (Inst)
 
Robert D. Frisina
Patents, Royalties, Other Intellectual Property - Patent Awarded for a new drug combination (hormone, anti-inflammatory) to treat age-related hearing loss. (Inst); Patent awarded for new neural stimulation technique involving laser light and gold nanoparticles (Inst)
 
Lois B. Travis
No Relationships to Disclose